Vor Biopharma raises $42m to advance development of cell therapy product candidate for AML

Image: Vor Biopharma has secured $42m funds to advance development of cell therapy product candidate for acute myeloid leukemia. Photo: courtesy of cooldesign / FreeDigitalPhotos.net.